Brian Seal

3.5k total citations · 2 hit papers
123 papers, 2.5k citations indexed

About

Brian Seal is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Brian Seal has authored 123 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 60 papers in Pulmonary and Respiratory Medicine and 26 papers in Economics and Econometrics. Recurrent topics in Brian Seal's work include Colorectal Cancer Treatments and Studies (21 papers), Economic and Financial Impacts of Cancer (19 papers) and Lung Cancer Treatments and Mutations (16 papers). Brian Seal is often cited by papers focused on Colorectal Cancer Treatments and Studies (21 papers), Economic and Financial Impacts of Cancer (19 papers) and Lung Cancer Treatments and Mutations (16 papers). Brian Seal collaborates with scholars based in United States, United Kingdom and Mexico. Brian Seal's co-authors include C. Daniel Mullins, Eberechukwu Onukwugha, Arif Hussain, Candice Yong, Amy J. Davidoff, Apar Kishor Ganti, Ion Cotarla, Engels Chou, Alyssa Klein and Martin J. Edelman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Brian Seal

120 papers receiving 2.5k citations

Hit Papers

Concordance between administrative claims and registry da... 2014 2026 2018 2022 2014 2021 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
    2014 511 citations Eberechukwu Onukwugha, Candice Yong et al. profile →
  2. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US
    2021 387 citations Ion Cotarla, Brian Seal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Seal United States 22 853 813 275 272 260 123 2.5k
Y Dündar United Kingdom 35 697 0.8× 511 0.6× 319 1.2× 152 0.6× 356 1.4× 94 3.1k
Chad M. Gundy Netherlands 35 1.3k 1.5× 1.0k 1.3× 135 0.5× 168 0.6× 351 1.4× 65 3.9k
S. Pampallona Switzerland 30 476 0.6× 779 1.0× 118 0.4× 163 0.6× 217 0.8× 81 3.3k
Peter C. Trask United States 30 1.1k 1.3× 2.2k 2.7× 191 0.7× 109 0.4× 234 0.9× 105 4.2k
Moshe Fridman United States 32 282 0.3× 674 0.8× 243 0.9× 98 0.4× 202 0.8× 132 3.8k
Karen K. Fields United States 23 572 0.7× 1.4k 1.8× 197 0.7× 97 0.4× 112 0.4× 48 3.0k
Sofia F. Garcia United States 23 320 0.4× 926 1.1× 252 0.9× 105 0.4× 223 0.9× 82 3.0k
Lidia Schapira United States 33 551 0.6× 2.1k 2.6× 182 0.7× 70 0.3× 333 1.3× 185 4.7k
Mike Hernández United States 33 702 0.8× 601 0.7× 90 0.3× 87 0.3× 982 3.8× 128 3.2k
Anita Y. Kinney United States 40 353 0.4× 1.8k 2.2× 249 0.9× 98 0.4× 237 0.9× 149 4.6k

Countries citing papers authored by Brian Seal

Since Specialization
Citations

This map shows the geographic impact of Brian Seal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Seal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Seal more than expected).

Fields of papers citing papers by Brian Seal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Seal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Seal. The network helps show where Brian Seal may publish in the future.

Co-authorship network of co-authors of Brian Seal

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Seal. A scholar is included among the top collaborators of Brian Seal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Seal. Brian Seal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seal, Brian, et al.. (2023). Clinical Outcomes By Child-Pugh Class in Patients With Advanced Hepatocellular Carcinoma in a Community Oncology Setting. SHILAP Revista de lepidopterología. 10(1). HEP47–HEP47. 6 indexed citations
2.
Yong, Candice, et al.. (2022). Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment. SHILAP Revista de lepidopterología. 7 indexed citations
3.
Lingohr-Smith, Melissa, et al.. (2021). Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA. SHILAP Revista de lepidopterología. 8(3). HEP37–HEP37. 3 indexed citations
4.
Onukwugha, Eberechukwu, Young Kwok, Jay P. Ciezki, et al.. (2017). Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone. PLoS ONE. 12(4). e0175956–e0175956. 3 indexed citations
5.
Galaznik, Aaron, Jill A. Bell, Michael E. Stokes, et al.. (2016). Systematic Review of Therapy Used in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Blood. 128(22). 3562–3562. 1 indexed citations
6.
Seal, Brian, et al.. (2015). Idelalisib Plus Rituximab Versus Placebo Plus Rituximab For Relapsed Chronic Lymphocytic Leukemia: A Cost-Effectiveness Analysis. Value in Health. 18(3). A203–A203. 2 indexed citations
7.
Seal, Brian, Sean D. Sullivan, Scott D. Ramsey, et al.. (2014). Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases. Applied Health Economics and Health Policy. 12(5). 547–557. 15 indexed citations
8.
Shaya, Fadia T., et al.. (2013). The Use Of Transarterial Chemoembolization For Treating Hepatocellular Carcinoma In The Seer-Medicare Population. Value in Health. 16(3). A1–A2. 1 indexed citations
9.
10.
11.
Shaya, Fadia T., et al.. (2013). Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival. Value in Health. 16(5). 760–768. 16 indexed citations
12.
13.
14.
Chastek, Benjamin, Mahesh Kulakodlu, Satish Valluri, & Brian Seal. (2012). CN4 Total Health Care Costs for Colorectal Cancer Patients Following Metastatic Diagnosis. Value in Health. 15(4). A1–A1. 1 indexed citations
15.
Skrepnek, Grant H., et al.. (2011). Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.. PubMed. 58(6). 484–92; quiz 493. 6 indexed citations
16.
Zuckerman, Ilene H., et al.. (2011). Chemotherapy Treatment and Survival in Older Women with Estrogen Receptor–Negative Metastatic Breast Cancer: A Population‐Based Analysis. Journal of the American Geriatrics Society. 59(4). 637–646. 18 indexed citations
17.
Davidoff, Amy J., James F. Gardner, Brian Seal, & Martin J. Edelman. (2011). Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(5). 934–941. 53 indexed citations
18.
Birnbaum, Howard G., Rym Ben-Hamadi, David Kelley, et al.. (2010). Assessing the Relationship Between Compliance With Antidepressant Therapy and Employer Costs Among Employees in the United States. Journal of Occupational and Environmental Medicine. 52(2). 115–124. 11 indexed citations
19.
Zeiger, Robert S., Joel W. Hay, Richard Contreras, et al.. (2008). Asthma costs and utilization in a managed care organization. Journal of Allergy and Clinical Immunology. 121(4). 885–892.e5. 30 indexed citations
20.
Ivanova, Jasmina, Howard G. Birnbaum, Matthew M. Hsieh, et al.. (2008). Adherence to inhaled corticosteroid use and local adverse events in persistent asthma.. PubMed. 14(12). 801–9. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y Dündar Breakdown of academic impact, for papers by Chad M. Gundy Breakdown of academic impact, for papers by S. Pampallona Breakdown of academic impact, for papers by Peter C. Trask Breakdown of academic impact, for papers by Moshe Fridman Breakdown of academic impact, for papers by Karen K. Fields Breakdown of academic impact, for papers by Sofia F. Garcia Breakdown of academic impact, for papers by Lidia Schapira Breakdown of academic impact, for papers by Mike Hernández Breakdown of academic impact, for papers by Anita Y. Kinney
Rankless by CCL
2026